CLNN
Price
$4.43
Change
-$0.08 (-1.77%)
Updated
Feb 21 closing price
Capitalization
36.88M
VKTX
Price
$34.07
Change
+$2.44 (+7.71%)
Updated
Feb 21 closing price
Capitalization
3.8B
59 days until earnings call
Ad is loading...

CLNN vs VKTX

Header iconCLNN vs VKTX Comparison
Open Charts CLNN vs VKTXBanner chart's image
Clene
Price$4.43
Change-$0.08 (-1.77%)
Volume$51.9K
Capitalization36.88M
Viking Therapeutics
Price$34.07
Change+$2.44 (+7.71%)
Volume$15.77M
Capitalization3.8B
CLNN vs VKTX Comparison Chart
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. VKTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Hold and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CLNN: $4.43 vs. VKTX: $34.07)
Brand notoriety: CLNN and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 86% vs. VKTX: 357%
Market capitalization -- CLNN: $36.88M vs. VKTX: $3.8B
CLNN [@Biotechnology] is valued at $36.88M. VKTX’s [@Biotechnology] market capitalization is $3.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • CLNN’s TA Score: 3 bullish, 6 bearish.
  • VKTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а -7.90% price change this week, while VKTX (@Biotechnology) price change was +11.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CLNN is expected to report earnings on Aug 12, 2024.

VKTX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.8B) has a higher market cap than CLNN($36.9M). VKTX YTD gains are higher at: -15.333 vs. CLNN (-16.573). CLNN has higher annual earnings (EBITDA): -29.61M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. CLNN (14.6M). VKTX has less debt than CLNN: VKTX (1.24M) vs CLNN (22.9M). CLNN has higher revenues than VKTX: CLNN (421K) vs VKTX (0).
CLNNVKTXCLNN / VKTX
Capitalization36.9M3.8B1%
EBITDA-29.61M-133.66M22%
Gain YTD-16.573-15.333108%
P/E RatioN/AN/A-
Revenue421K0-
Total Cash14.6M930M2%
Total Debt22.9M1.24M1,854%
FUNDAMENTALS RATINGS
CLNN vs VKTX: Fundamental Ratings
CLNN
VKTX
OUTLOOK RATING
1..100
7916
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
6388
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
2750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (49) in the Biotechnology industry is somewhat better than the same rating for CLNN (83) in the null industry. This means that VKTX’s stock grew somewhat faster than CLNN’s over the last 12 months.

VKTX's Profit vs Risk Rating (60) in the Biotechnology industry is somewhat better than the same rating for CLNN (100) in the null industry. This means that VKTX’s stock grew somewhat faster than CLNN’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that VKTX’s stock grew similarly to CLNN’s over the last 12 months.

CLNN's Price Growth Rating (63) in the null industry is in the same range as VKTX (88) in the Biotechnology industry. This means that CLNN’s stock grew similarly to VKTX’s over the last 12 months.

CLNN's P/E Growth Rating (95) in the null industry is in the same range as VKTX (100) in the Biotechnology industry. This means that CLNN’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLNNVKTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GIS61.001.81
+3.06%
General Mills
WU10.66-0.08
-0.74%
Western Union Company (The)
NIC117.03-2.18
-1.83%
Nicolet BanksharesInc
MDAI1.95-0.04
-2.01%
Spectral AI
AMLX3.30-0.22
-6.25%
Amylyx Pharmaceuticals

CLNN and

Correlation & Price change

A.I.dvisor tells us that CLNN and KZIA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLNN and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
-1.77%
KZIA - CLNN
33%
Poorly correlated
+0.11%
GOSS - CLNN
30%
Poorly correlated
-8.50%
QNCX - CLNN
29%
Poorly correlated
-3.45%
VRNA - CLNN
28%
Poorly correlated
+5.87%
VKTX - CLNN
28%
Poorly correlated
+7.71%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+7.71%
JANX - VKTX
61%
Loosely correlated
-3.12%
DNLI - VKTX
48%
Loosely correlated
-3.98%
LGND - VKTX
44%
Loosely correlated
-1.10%
ALT - VKTX
42%
Loosely correlated
-3.02%
BEAM - VKTX
40%
Loosely correlated
-8.18%
More